The deleterious effect of AT1-AA is consistent with several previous studies showing the enhancing effect of AT1 overactivity on dopaminergic degeneration16,33, and the neuroprotective effects of drugs such as candesartan and telmisartan in PD animal models and clinical studies15,16,33. Here, AGTR1 is linked to Parkinson disease.